Advertisement

Topics

Companies Related to "With Headway NASH Madrigal Pharma Considering Sale" [Most Relevant Company Matches] RSS

05:59 EDT 21st October 2018 | BioPortfolio

Here are the most relevant search results for "With Headway NASH Madrigal Pharma Considering Sale" found in our extensive corporate database of over 50,000 company records.

Showing "With Headway NASH Madrigal Pharma Considering Sale" Companies 1–25 of 1,100+

Relevant

Nash Finch Company


Jecure Therapeutics

Jecure is focused on the discovery of novel therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. Jecure’s scientific founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician scientist in hepatology. With operations in the biotech hub of San Diego, Califo...

Patricia Nash

The quintessential embodiment of style, form and function, Patricia Nash Designs creates handbags and accessories that are made of beautiful, vegetable tanned Italian leather. The company was founded in 2012 by the designer Patricia Nash who was inspired by her extensive international travels and vintage handbags found in her mother’s closet. The coll...


Inversago Pharma Inc.

A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome (PWS), type 1 diabetes (T1D), obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH). Inversago’s techno...

North American Specialty Hospital

Headquartered in Denver, NASH is a US majority-owned and managed enterprise. Incorporating US physicians in its service delivery, NASH is designed to provide pre-operative and post-operative services throughout the US, while providing clinical care in Cancun. http://northamericanspecialtyhospital.com/

POXEL S.A.

Poxel uses its development expertise in metabolism to advance a pipeline of drug candidates focused on the treatment of metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH). We have successfully completed the Phase 2 clinical program for our first-in-class lead product, Imeglimin, which targets mitochondrial dysfunction, ...

HARVEY NASH GROUP

Harvey Nash was founded in London in 1988. David Higgins, the current Executive Vice Chairman, was one of the original founders and still has a sizeable financial stake in the company. Early on, the management broadened the Group’s geographical coverage and increased the range of services, recognising the value this would add to the business in the longer term. An IPO in April 1997 facilitated a...

Celtic Pharma Holdings Advisors LLP

Celtic Pharma Holdings Advisors is a global private equity fund management partnership focused on the biotechnology and pharmaceutical industries. Our second fund, Celtic Pharma Holdings II LP, invests in companies which own proven technology platforms and early clinical development-stage pharmaceutical programmes and directs the management of these programmes through their development prior t...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and partnering with the research community to efficiently develop and bring medical innovations to market. At H3 Pharma, we highly value Inventors and share their passion for Helping Human Health

Kensey Nash Corp.

Jake Nash

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more than 100 years of history as an independent, research-based specialty pharmaceutical company.

Kensey Nash Corporation

Corey McPherson Nash

Mayne Pharma Ltd.

Mayne Pharma Limited focuses on the development, manufacture, sale and distribution of medicines used by oncologists. The company is listed on the Australian Stock Exchange under the code “MYP”.Mayne Pharma’s product portfolio has been built on world class process development capabilities in the two families of drugs that are commonly used in the treatment of cancer today: taxanes and pla...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, BioCis Pharma Oy and Oy Lx Therapies Ltd. More information can be found at www.laurantis.com.

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. FranceMed Pharma is certified to ISO 9001 and ISO 13485.

Pharma Active

Pharmaceutical industry has become one of the fastest growing industry. With growth comes the need for experienced professionals and various resources such as clinical trial centres, toxicology centres, contract research organisations etc. Pharma companies Pharma active also provides common platform to those who share mutual interest in Pharma sector.

PlasmaSelect AG

1998 January 1998 foundation of PlasmaSelect GmbH1999 - November 1999 conversion to PlasmaSelect AG2000- IPO March 1, 20002001- Acquisition of DeltaPharma (DeltaSelect) in Pfullingen- Acquisition of Klemenz (infusion solutions factory) in Pfullingen- Objective: alternative business, basic business2002 In October 2002, sale of adsorber technology and the respective plant in Teterow2003- Takeover o...

CROMA-PHARMA GmbH

CROMA-PHARMA is a family owned, internationally orientated pharmaceutical company, based in Korneuburg, Austria. CROMA-PHARMA´s areas of activity are orthopedics, ophthalmology, dermatology and contract manufacturing. CROMA-PHARMA is dedicated to improving people’s quality of life through innovative, consistently simple and effective health solutio...

Flex Pharma, Inc.

Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma has demonstrated initial human efficacy related to muscle cramping in healthy volunteers. The Company plans to initiate efficacy studies in patients with neuromuscular disorders in the first half of 2015. Additiona...

Pharma in Focus

Pharma in Focus is Australia 's only independent pharma industry news service.We deliver up-to-date, in-depth news, analysis and opinion straight to your desktop 48 times a year, covering the whole pharma sector, both prescription and non-prescription in Australia and New Zealand.

SCHWARZ PHARMA, Inc

SCHWARZ PHARMA, Inc. is the U.S. headquarters of SCHWARZ PHARMA AG, a mid-sized, multi-national pharmaceutical company focusing on the development and marketing of innovative therapeutics. SCHWARZ PHARMA leverages its strengths to secure new product flow through collaborative alliances with academia, research organizations and biotech companies. This development strategy is supported and funded by...

LifeCycle Pharma

LifeCycle Pharma was founded in June 2002 as a spin-off from H. Lundbeck A/S. Its investors include H. Lundbeck A/S, Novo A/S, Nordic Biotech, Alta Partners (USA), and Adamant Biomedical Investments (Switzerland) as well as the LifeCycle Pharma executives. LifeCycle Pharma utilizes its proprietary Meltdose® technology to improve the bioavailability of known and established compounds so that patie...

BHR Pharma, LLC

Founded in January 2008, BHR Pharma, LLC (www.bhr-pharma.com) is a pharmaceutical research and development (R&D) company located near Washington, DC. BHR is committed to bringing to market specialty treatments that employ non-oral delivery systems, with an emphasis on unmet and underserved medical needs.


More From BioPortfolio on "With Headway NASH Madrigal Pharma Considering Sale"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks